PRMT5 and cancer: PRMT5 ablation alone also recapitulates FA pathway deficiency seen in MTAP-deleted tumors (30), mimicked by the use of MAT2A inhibitors in MTAP-deleted cancers that was found to be synergistic with docetaxel in squamous lung and pancreatic PDX models (43).